Pfizer And BioNTech Seek Covid Vaccine Approval For 12-15-Year Olds In EU

The companies have submitted a request with the European Medicines Agency (EMA) to expand the current emergency approval for their jab to include "adolescents 12 to 15 years of age", they said in a statement

Pfizer/BioNTech said Friday they have asked European regulators to authorise their Covid-19 vaccine for 12 to 15-year-old, following a similar move in the United States earlier this month. The companies have submitted a request with the European Medicines Agency (EMA) to expand the current emergency approval for their jab to include "adolescents 12 to 15 years of age", they said in a statement. BioNTech CEO Ugur Sahin said Thursday the jab could be available for those age groups from June.